AI-generated summary
The authors randomized 40 patients with temporomandibular disorders to GaAlAs laser at 830 nm or placebo, applied twice weekly for four weeks. They report greater reductions in painful symptoms in the laser group than in the placebo group, and improved jaw movement range at the final follow-up, and suggest laser may be a supportive therapy.
- Participants
- 40
- Who or what was studied
- Patients with temporomandibular disorders (TMD)
- Wavelengths
- 830 nm
- Limits stated in the abstract
- The abstract does not report the statistical details behind its conclusions or any long-term follow-up beyond 30 days, and it does not state how the placebo was blinded.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on scielo.br.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 830 nm
- Power
- 40 mW
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Low-level laser therapy, Fluence, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.